These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2735661

  • 1. Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Van Ryn-McKenna J, Ofosu FA, Gray E, Hirsh J, Buchanan MR.
    Ann N Y Acad Sci; 1989; 556():304-12. PubMed ID: 2735661
    [Abstract] [Full Text] [Related]

  • 2. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA.
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP, Merton RE, Barrowcliffe TW.
    Ann N Y Acad Sci; 1989 Sep; 556():313-22. PubMed ID: 2735662
    [Abstract] [Full Text] [Related]

  • 4. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA.
    Biochem J; 1987 Dec 15; 248(3):889-96. PubMed ID: 2963622
    [Abstract] [Full Text] [Related]

  • 5. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA.
    Ann N Y Acad Sci; 1989 Dec 15; 556():123-31. PubMed ID: 2525356
    [Abstract] [Full Text] [Related]

  • 6. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR, Boneu B, Ofosu F, Hirsh J.
    Blood; 1985 Jan 15; 65(1):198-201. PubMed ID: 3965047
    [Abstract] [Full Text] [Related]

  • 7. The haemorrhagic and antithrombotic effects of dermatan sulphate.
    Fernandez F, Van Ryn J, Ofosu FA, Hirsh J, Buchanan MR.
    Br J Haematol; 1986 Oct 15; 64(2):309-17. PubMed ID: 3778825
    [Abstract] [Full Text] [Related]

  • 8. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA.
    J Lab Clin Med; 1991 May 15; 117(5):359-64. PubMed ID: 2019790
    [Abstract] [Full Text] [Related]

  • 9. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J, Gray E, Weber E, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1989 Feb 28; 61(1):7-9. PubMed ID: 2473537
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 Feb 28; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA, Modi GJ, Hirsh J, Buchanan MR, Blajchman MA.
    Ann N Y Acad Sci; 1986 Feb 28; 485():41-55. PubMed ID: 2436525
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR, Brister SJ.
    Thromb Res; 2000 Sep 15; 99(6):603-12. PubMed ID: 10974347
    [Abstract] [Full Text] [Related]

  • 13. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF, Ellis V, Seno N, Kakkar VV.
    Biochem J; 1988 Sep 01; 254(2):547-51. PubMed ID: 2902851
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA, Choay J, Anvari N, Smith LM, Blajchman MA.
    Eur J Biochem; 1990 Oct 24; 193(2):485-93. PubMed ID: 2226466
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Maggi A, Abbadini M, Pagella PG, Borowska A, Pangrazzi J, Donati MB.
    Haemostasis; 1987 Oct 24; 17(6):329-35. PubMed ID: 3428718
    [Abstract] [Full Text] [Related]

  • 19. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE, Thomas DP.
    Thromb Haemost; 1987 Oct 28; 58(3):839-42. PubMed ID: 3433248
    [Abstract] [Full Text] [Related]

  • 20. Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
    Boneu B, Buchanan MR, Cade JF, Van Ryn J, Fernandez FF, Ofosu FA, Hirsh J.
    Thromb Res; 1985 Oct 01; 40(1):81-9. PubMed ID: 4089829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.